Equity Overview
Price & Market Data
Price: $0.386
Daily Change: $0.00 / 0.00%
Daily Range: $0.386 - $0.401
Market Cap: $20,024,231
Daily Volume: 500
Performance Metrics
1 Week: 0.86%
1 Month: 0.86%
3 Months: -33.76%
6 Months: -33.76%
1 Year: -12.20%
YTD: -3.42%
Details
Thiogenesis Therapeutics, Corp., a clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs. Its lead product candidate is TTI-0102, a prodrug that consists of cysteamine for use in the treatment of mitochondrial encephalopathy lactic acidosis and stroke-like episodes, leigh syndrome, pediatric metabolic dysfunction-associated steatohepatitis, and rett syndrome. The company is headquartered in Toronto, Canada.